Medical Care

Global Microbiome Modulator Market Research Report 2026

This report delivers a comprehensive overview of the global Microbiome Modulator market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microbiome Modulator. The Microbiome Modulator market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microbiome Modulator market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microbiome Modulator manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi
DSM
DuPont
BioGaia
Chr. Hansen
Ingredion
Immuron
MICROBIOME THERAPEUTICS
Quorum Innovations
Merck Sharp & Dohme
Symbiotix Biotherapies
Ritter Pharmaceuticals
Segment by Type
Prebiotics
Probiotics
Drugs
Other
Segment by Application
Hospital
Specialty Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microbiome Modulator companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Modulator Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Prebiotics
1.2.3 Probiotics
1.2.4 Drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Microbiome Modulator Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Modulator Market Perspective (2021–2032)
2.2 Global Microbiome Modulator Growth Trends by Region
2.2.1 Global Microbiome Modulator Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microbiome Modulator Historic Market Size by Region (2021–2026)
2.2.3 Microbiome Modulator Forecasted Market Size by Region (2027–2032)
2.3 Microbiome Modulator Market Dynamics
2.3.1 Microbiome Modulator Industry Trends
2.3.2 Microbiome Modulator Market Drivers
2.3.3 Microbiome Modulator Market Challenges
2.3.4 Microbiome Modulator Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Modulator Players by Revenue
3.1.1 Global Top Microbiome Modulator Players by Revenue (2021–2026)
3.1.2 Global Microbiome Modulator Revenue Market Share by Players (2021–2026)
3.2 Global Top Microbiome Modulator Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microbiome Modulator Revenue
3.4 Global Microbiome Modulator Market Concentration Ratio
3.4.1 Global Microbiome Modulator Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Modulator Revenue in 2025
3.5 Global Key Players of Microbiome Modulator Head Offices and Areas Served
3.6 Global Key Players of Microbiome Modulator, Products and Applications
3.7 Global Key Players of Microbiome Modulator, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microbiome Modulator Breakdown Data by Type
4.1 Global Microbiome Modulator Historic Market Size by Type (2021–2026)
4.2 Global Microbiome Modulator Forecasted Market Size by Type (2027–2032)
5 Microbiome Modulator Breakdown Data by Application
5.1 Global Microbiome Modulator Historic Market Size by Application (2021–2026)
5.2 Global Microbiome Modulator Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microbiome Modulator Market Size (2021–2032)
6.2 North America Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microbiome Modulator Market Size by Country (2021–2026)
6.4 North America Microbiome Modulator Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiome Modulator Market Size (2021–2032)
7.2 Europe Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microbiome Modulator Market Size by Country (2021–2026)
7.4 Europe Microbiome Modulator Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Modulator Market Size (2021–2032)
8.2 Asia-Pacific Microbiome Modulator Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microbiome Modulator Market Size by Region (2021–2026)
8.4 Asia-Pacific Microbiome Modulator Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microbiome Modulator Market Size (2021–2032)
9.2 Latin America Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microbiome Modulator Market Size by Country (2021–2026)
9.4 Latin America Microbiome Modulator Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Modulator Market Size (2021–2032)
10.2 Middle East & Africa Microbiome Modulator Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microbiome Modulator Market Size by Country (2021–2026)
10.4 Middle East & Africa Microbiome Modulator Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Microbiome Modulator Introduction
11.1.4 Sanofi Revenue in Microbiome Modulator Business (2021–2026)
11.1.5 Sanofi Recent Development
11.2 DSM
11.2.1 DSM Company Details
11.2.2 DSM Business Overview
11.2.3 DSM Microbiome Modulator Introduction
11.2.4 DSM Revenue in Microbiome Modulator Business (2021–2026)
11.2.5 DSM Recent Development
11.3 DuPont
11.3.1 DuPont Company Details
11.3.2 DuPont Business Overview
11.3.3 DuPont Microbiome Modulator Introduction
11.3.4 DuPont Revenue in Microbiome Modulator Business (2021–2026)
11.3.5 DuPont Recent Development
11.4 BioGaia
11.4.1 BioGaia Company Details
11.4.2 BioGaia Business Overview
11.4.3 BioGaia Microbiome Modulator Introduction
11.4.4 BioGaia Revenue in Microbiome Modulator Business (2021–2026)
11.4.5 BioGaia Recent Development
11.5 Chr. Hansen
11.5.1 Chr. Hansen Company Details
11.5.2 Chr. Hansen Business Overview
11.5.3 Chr. Hansen Microbiome Modulator Introduction
11.5.4 Chr. Hansen Revenue in Microbiome Modulator Business (2021–2026)
11.5.5 Chr. Hansen Recent Development
11.6 Ingredion
11.6.1 Ingredion Company Details
11.6.2 Ingredion Business Overview
11.6.3 Ingredion Microbiome Modulator Introduction
11.6.4 Ingredion Revenue in Microbiome Modulator Business (2021–2026)
11.6.5 Ingredion Recent Development
11.7 Immuron
11.7.1 Immuron Company Details
11.7.2 Immuron Business Overview
11.7.3 Immuron Microbiome Modulator Introduction
11.7.4 Immuron Revenue in Microbiome Modulator Business (2021–2026)
11.7.5 Immuron Recent Development
11.8 MICROBIOME THERAPEUTICS
11.8.1 MICROBIOME THERAPEUTICS Company Details
11.8.2 MICROBIOME THERAPEUTICS Business Overview
11.8.3 MICROBIOME THERAPEUTICS Microbiome Modulator Introduction
11.8.4 MICROBIOME THERAPEUTICS Revenue in Microbiome Modulator Business (2021–2026)
11.8.5 MICROBIOME THERAPEUTICS Recent Development
11.9 Quorum Innovations
11.9.1 Quorum Innovations Company Details
11.9.2 Quorum Innovations Business Overview
11.9.3 Quorum Innovations Microbiome Modulator Introduction
11.9.4 Quorum Innovations Revenue in Microbiome Modulator Business (2021–2026)
11.9.5 Quorum Innovations Recent Development
11.10 Merck Sharp & Dohme
11.10.1 Merck Sharp & Dohme Company Details
11.10.2 Merck Sharp & Dohme Business Overview
11.10.3 Merck Sharp & Dohme Microbiome Modulator Introduction
11.10.4 Merck Sharp & Dohme Revenue in Microbiome Modulator Business (2021–2026)
11.10.5 Merck Sharp & Dohme Recent Development
11.11 Symbiotix Biotherapies
11.11.1 Symbiotix Biotherapies Company Details
11.11.2 Symbiotix Biotherapies Business Overview
11.11.3 Symbiotix Biotherapies Microbiome Modulator Introduction
11.11.4 Symbiotix Biotherapies Revenue in Microbiome Modulator Business (2021–2026)
11.11.5 Symbiotix Biotherapies Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Details
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Microbiome Modulator Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Microbiome Modulator Business (2021–2026)
11.12.5 Ritter Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Microbiome Modulator Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Prebiotics
Table 3. Key Players of Probiotics
Table 4. Key Players of Drugs
Table 5. Key Players of Other
Table 6. Global Microbiome Modulator Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microbiome Modulator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Microbiome Modulator Market Size by Region (US$ Million), 2021–2026
Table 9. Global Microbiome Modulator Market Share by Region (2021–2026)
Table 10. Global Microbiome Modulator Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Microbiome Modulator Market Share by Region (2027–2032)
Table 12. Microbiome Modulator Market Trends
Table 13. Microbiome Modulator Market Drivers
Table 14. Microbiome Modulator Market Challenges
Table 15. Microbiome Modulator Market Restraints
Table 16. Global Microbiome Modulator Revenue by Players (US$ Million), 2021–2026
Table 17. Global Microbiome Modulator Market Share by Players (2021–2026)
Table 18. Global Top Microbiome Modulator Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microbiome Modulator Revenue, 2025
Table 19. Ranking of Global Top Microbiome Modulator Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Microbiome Modulator Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Microbiome Modulator, Headquarters and Area Served
Table 22. Global Key Players of Microbiome Modulator, Products and Applications
Table 23. Global Key Players of Microbiome Modulator, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Microbiome Modulator Market Size by Type (US$ Million), 2021–2026
Table 26. Global Microbiome Modulator Revenue Market Share by Type (2021–2026)
Table 27. Global Microbiome Modulator Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Microbiome Modulator Revenue Market Share by Type (2027–2032)
Table 29. Global Microbiome Modulator Market Size by Application (US$ Million), 2021–2026
Table 30. Global Microbiome Modulator Revenue Market Share by Application (2021–2026)
Table 31. Global Microbiome Modulator Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Microbiome Modulator Revenue Market Share by Application (2027–2032)
Table 33. North America Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 35. North America Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Microbiome Modulator Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Microbiome Modulator Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Microbiome Modulator Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Microbiome Modulator Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Microbiome Modulator Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Microbiome Modulator Market Size by Country (US$ Million), 2027–2032
Table 48. Sanofi Company Details
Table 49. Sanofi Business Overview
Table 50. Sanofi Microbiome Modulator Product
Table 51. Sanofi Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 52. Sanofi Recent Development
Table 53. DSM Company Details
Table 54. DSM Business Overview
Table 55. DSM Microbiome Modulator Product
Table 56. DSM Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 57. DSM Recent Development
Table 58. DuPont Company Details
Table 59. DuPont Business Overview
Table 60. DuPont Microbiome Modulator Product
Table 61. DuPont Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 62. DuPont Recent Development
Table 63. BioGaia Company Details
Table 64. BioGaia Business Overview
Table 65. BioGaia Microbiome Modulator Product
Table 66. BioGaia Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 67. BioGaia Recent Development
Table 68. Chr. Hansen Company Details
Table 69. Chr. Hansen Business Overview
Table 70. Chr. Hansen Microbiome Modulator Product
Table 71. Chr. Hansen Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 72. Chr. Hansen Recent Development
Table 73. Ingredion Company Details
Table 74. Ingredion Business Overview
Table 75. Ingredion Microbiome Modulator Product
Table 76. Ingredion Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 77. Ingredion Recent Development
Table 78. Immuron Company Details
Table 79. Immuron Business Overview
Table 80. Immuron Microbiome Modulator Product
Table 81. Immuron Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 82. Immuron Recent Development
Table 83. MICROBIOME THERAPEUTICS Company Details
Table 84. MICROBIOME THERAPEUTICS Business Overview
Table 85. MICROBIOME THERAPEUTICS Microbiome Modulator Product
Table 86. MICROBIOME THERAPEUTICS Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 87. MICROBIOME THERAPEUTICS Recent Development
Table 88. Quorum Innovations Company Details
Table 89. Quorum Innovations Business Overview
Table 90. Quorum Innovations Microbiome Modulator Product
Table 91. Quorum Innovations Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 92. Quorum Innovations Recent Development
Table 93. Merck Sharp & Dohme Company Details
Table 94. Merck Sharp & Dohme Business Overview
Table 95. Merck Sharp & Dohme Microbiome Modulator Product
Table 96. Merck Sharp & Dohme Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 97. Merck Sharp & Dohme Recent Development
Table 98. Symbiotix Biotherapies Company Details
Table 99. Symbiotix Biotherapies Business Overview
Table 100. Symbiotix Biotherapies Microbiome Modulator Product
Table 101. Symbiotix Biotherapies Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 102. Symbiotix Biotherapies Recent Development
Table 103. Ritter Pharmaceuticals Company Details
Table 104. Ritter Pharmaceuticals Business Overview
Table 105. Ritter Pharmaceuticals Microbiome Modulator Product
Table 106. Ritter Pharmaceuticals Revenue in Microbiome Modulator Business (US$ Million), 2021–2026
Table 107. Ritter Pharmaceuticals Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report


List of Figures
Figure 1. Microbiome Modulator Picture
Figure 2. Global Microbiome Modulator Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microbiome Modulator Market Share by Type: 2025 vs 2032
Figure 4. Prebiotics Features
Figure 5. Probiotics Features
Figure 6. Drugs Features
Figure 7. Other Features
Figure 8. Global Microbiome Modulator Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Microbiome Modulator Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Specialty Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Microbiome Modulator Report Years Considered
Figure 14. Global Microbiome Modulator Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Microbiome Modulator Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Microbiome Modulator Market Share by Region: 2025 vs 2032
Figure 17. Global Microbiome Modulator Market Share by Players in 2025
Figure 18. Global Microbiome Modulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Microbiome Modulator Revenue in 2025
Figure 20. North America Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Microbiome Modulator Market Share by Country (2021–2032)
Figure 22. United States Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Microbiome Modulator Market Share by Country (2021–2032)
Figure 26. Germany Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Microbiome Modulator Market Share by Region (2021–2032)
Figure 34. China Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Microbiome Modulator Market Share by Country (2021–2032)
Figure 42. Mexico Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Microbiome Modulator Market Share by Country (2021–2032)
Figure 46. Israel Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Microbiome Modulator Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Sanofi Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 50. DSM Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 51. DuPont Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 52. BioGaia Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 53. Chr. Hansen Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 54. Ingredion Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 55. Immuron Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 56. MICROBIOME THERAPEUTICS Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 57. Quorum Innovations Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 58. Merck Sharp & Dohme Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 59. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 60. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Modulator Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies